XNAS · AMRX
+0.35% · +$0.0600 · Vol 2.5M
Market closed · last close 4:00 PM ET · price as of 19:41:24 ET
Amneal Pharmaceuticals, Inc. Class A Common Stock

Amneal Pharmaceuticals, Inc. Class A Common Stock

PHARMACEUTICAL PREPARATIONS
$17.33

Veridion Score

Refresh
Score snapshot refresh in progress
Veridion Score History · 90D

Composite trend over time

HISTORY REFRESH IN PROGRESS
REFRESHES DAILY
AI Analysis
Sovereign

Why is AMRX moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
About Amneal Pharmaceuticals, Inc. Class A Common Stock
PHARMACEUTICAL PREPARATIONS
Listed since
2018
Employees
9K
Country
US

Amneal Pharmaceuticals Inc is a pharmaceutical company operating in the U.S., India, and Ireland. With three reportable segments; Affordable Medicines, Specialty, and AvKARE. It develops, manufactures, and distributes a diverse portfolio of essential medicines. The Affordable Medicines segment, which derives maximum revenue, focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.

Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$17.39
Day high
$17.77
Day low
$17.21
Previous close
$17.27
52W high
$17.77
-2.50% from high
52W low
$15.32
82% of range
Market cap
$5.5B
P/E
55.90×
EPS
$0.3100
Shares out
319M
Volume
2.5M
VWAP
$17.44
Price history computed in-house
1W
+6.91%
SMA 50 $16.41 · above
SMA 200 $16.41 · above
52W position 82%
Veridion warehouse edge

Warehouse intelligence for AMRX.

Disclosure-sourced lobbying and contract detail remains attributed in the full panels below.
Data ledger
Quote and day range
Refresh interval: 30 seconds
Source: Market data
Veridion Score
Coverage building
Chart and risk context
Daily bars with no missing-bar fill
Source: Market data
News and filings
Refresh intervals shown inside each panel
Source: Market news and federal filings
Financials
Statements refresh in progress
SEC Form 4 ledger

AMRX insider activity

Amneal Pharmaceuticals, Inc. Class A Common Stock

Score
Coverage building
Pressure
Net selling
Filings
43
Buys / sells
3 / 40
Net value
-$35.2M
Insiders
9
Named filers
AM
Autor Deborah M.
Insider
Leadership
PC
Patel Chintu
Insider
Leadership
PK
Patel Chirag K.
Insider
Leadership
Cluster

No multi-insider buying cluster in the last 90 days

Net pressure

Net selling: -$35.2M across loaded Form 4 rows.

Convergence not established

Loaded official disclosures do not show all three sources aligned on this ticker.

Filing dateTrade dateInsiderTitleTypePriceQtyOwnedValueReceipt
2026-05-122026-05-11Autor Deborah M.Insidersell$12.9434,81993,660$451KSEC Form 4
2026-03-052026-03-04Patel ChintuInsidersell$13.3028,9831,388,521$385KSEC Form 4
2026-03-052026-03-04Patel Chirag K.Insidersell$13.3037,8251,393,470$503KSEC Form 4
2026-03-052026-03-04Daly Jason B.Insidersell$13.3015,580251,784$207KSEC Form 4
2026-03-052026-03-04Shah NikitaInsidersell$13.3017,976399,793$239KSEC Form 4
Full Form 4 history requires Sovereign

Showing 5 recent rows. Sovereign unlocks 38 additional rows, full sorting, and the named-filer history.

Upgrade to Sovereign · $25/mo
Source: SEC EDGAR Form 4. Rows with missing price or quantity are excluded rather than zero-filled.Methodology
Congress · 90D
Congress filing snapshot refresh in progress
Federal contracts

AMRX contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for AMRX in this window.
Lobbying spend

AMRX lobbying filings, year to date.

Registered lobbying filings matched to Amneal Pharmaceuticals, Inc. Class A Common Stock.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for AMRX in this window.
Latest news · AMRX
Refresh interval: 5 minutes · Source: Market news insights
News snapshot refresh in progress
Analyst ratings
Sovereign unlock shows live analyst consensus for AMRX.
Options
Sovereign unlock shows live options positioning for AMRX.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.